Fresh analysis indicates that individuals who discontinue blockbuster slimming jabs like Wegovy and Mounjaro tend to recover shed pounds far faster than those who end traditional diet and exercise regimens.
Published data in a major health publication shows that while obese individuals can lose a large proportion of their body weight while using the jabs, the weight comes back at an average rate of 0.8 kg per month once they quit.
"People purchasing such treatments must be cognizant of the risk of rapid rebound weight gain when the therapy ends," stated researcher Dr. Susan Jebb.
This pace of recovery means a return to starting weight within about 18 months.
Analyzing Approaches
The study, which examined dozens of studies involving over 9,000 of participants, contrasted the effects of the injectable medications with other pills.
The team note that individuals who lose weight through diet and exercise typically have a more gradual weight regain—approximately 100 grams monthly—post-intervention.
Explaining the Fast Regain
Doctors suggest the mode of action of the injections is key to understanding the amplified rebound.
The injections imitate a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Long-term administration of GLP-1 concentrations far above than normal could lead to the system to produce less of its own natural hormone, and may also lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this GLP-1 'fix' means hunger is unsuppressed, making binge eating far more likely."
A Chronic Condition?
Health authorities suggest the jabs for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.
Many experts contend that, given the significant potential of weight regain, the treatment is often ongoing.
This perspective is supported by drug manufacturers, who state that the findings "underscore the chronic nature of obesity," similar to managing diseases like hypertension.
User Experiences
Users who have stopped the medication report a sudden return of appetite.
"It felt as if something activating and I was suddenly starving," described one woman.
This challenge is exacerbated if individuals have not adopted lasting lifestyle or habit modifications during treatment.
Growing Interest
Recent estimates suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with desire being substantial.
- Use is more common among females than men.
- The 40s and 50s demographic shows the highest level of interest.
- Many access the drugs through private healthcare rather than the NHS.
In conclusion, experts emphasize that while these medications are powerful agents for shedding pounds, they are not a standalone fix and lasting health benefits likely depends on integrated behavioural changes.
